A Huppert, G Katriel - Clinical microbiology and infection, 2013 - Elsevier
We discuss to what extent disease transmission models provide reliable predictions. The concept of prediction is delineated as it is understood by modellers, and illustrated by some …
A Jemal, EP Simard, C Dorell, AM Noone… - Journal of the …, 2013 - academic.oup.com
Abstract Background The American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American …
Importance Oropharynx cancer (OPC) incidence has increased for several decades in the US. It is unclear when and how this trend will be affected by current HPV vaccination trends …
L Lee, SM Garland - F1000Research, 2017 - ncbi.nlm.nih.gov
We currently have the knowledge and experience to prevent much of human papillomavirus (HPV)-related disease burden globally. In many countries where prophylactic HPV …
Background Bivalent and quadrivalent human papillomavirus (HPV) vaccines are now licensed in several countries. Furthermore, clinical trials examining the efficacy of a …
Objective To assess the reduction in the vaccine preventable burden of cancer in men if boys are vaccinated along with girls against oncogenic human papillomavirus (HPV) …
Abstract In 2020, the World Health Organization (WHO) launched a strategy to eliminate cervical cancer as a public health problem. To support the strategy, the WHO published …
H Bergman, BS Buckley, G Villanueva… - Cochrane database …, 1996 - cochranelibrary.com
Background Uptake of human papillomavirus (HPV) vaccine remains low in many countries, although the bivalent and quadrivalent HPV vaccines given as a three‐dose schedule are …
K Canfell, H Chesson, SL Kulasingam, J Berkhof… - Vaccine, 2012 - Elsevier
Over the last 5 years, prophylactic vaccination against human papillomavirus (HPV) in pre- adolescent females has been introduced in most developed countries, supported by …